Miriam Kimel

Impact of adalimumab treatment on patient‐reported outcomes: Results from a Phase III clinical trial in patients with moderate to severe plaque psoriasis

Dennis A. Revicki, Mary Kaye Willian, Alan Menter et al. · Journal of Dermatological Treatment · 2007 · 102 citations

Adalimumab plus methotrexate improved SF-36 scores and reduced the effect of rheumatoid arthritis (RA) on work activity for patients with early RA.

Miriam Kimel, Mary Cifaldi, Naijun Chen et al. · PubMed · 2008 · 72 citations

Reliability and Construct Validity of the NEI VFQ-25 in a Subset of Patients With Geographic Atrophy From the Phase 2 Mahalo Study

Sobha Sivaprasad, Elizabeth Tschosik, Audrey Kapre et al. · American Journal of Ophthalmology · 2018 · 51 citations · Full text

Adalimumab improves health-related quality of life in patients with moderate to severe plaque psoriasis compared with the United States general population norms: Results from a randomized, controlled Phase III study

Dennis A. Revicki, Alan Menter, Steven R. Feldman et al. · Health and Quality of Life Outcomes · 2008 · 43 citations · Full text

Functional Reading Independence (FRI) Index: A New Patient-Reported Outcome Measure for Patients With Geographic Atrophy

Miriam Kimel, Nancy Kline Leidy, Elizabeth Tschosik et al. · Investigative Ophthalmology & Visual Science · 2016 · 41 citations · Full text